AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Exclusive rights obtained to HIV microbicide candidate.(cyanovirin-N from Biosyn Inc. )
2003 MAY 1 - (NewsRx.com & NewsRx.net) -- Biosyn, Inc., announced that the company has acquired exclusive, worldwide rights from the U.S. National Institutes of Health (NIH) for the development and commercialization of the novel protein, cyanovirin-N, as an HIV microbicide.
Cyanovirin-N (CV-N) has shown remarkably potent anti-HIV activity in laboratory studies and in animal models. Based on these data, Biosyn foresees significant potential in the development of CV-N as a microbicide to prevent the sexual transmission of HIV.
CV-N is a novel protein isolated from the cyanobacterium, Nostoc ellipsosporum (blue-green algae). Promising results of NIH research into the protein's use in preventing HIV included a primate model in which CV-N was shown to prevent transmission of simian-human immunodeficiency virus (SHIV), an HIV-like virus that infects monkeys. "CV-N is a member of an exciting new class of HIV drugs termed fusion inhibitors," stated Richard Bax, VP and chief scientific officer of Biosyn.
"By preventing HIV entry into and fusion with target cells, CV-N effectively inhibits the virus' mode of infection. As an intravaginal gel applied prior to intercourse, CV-N could help to avert the ...
- Biosyn, Inc. Obtains Exclusive Rights to Novel HIV Microbicide Candidate from...
- Press release article from: PR Newswire April 3, 2003 700+ words
...Based on these data, Biosyn foresees significant...the development of CV-N as a microbicide...Scientific Officer of Biosyn. "By preventing...with target cells, CV-N effectively inhibits...development program for CV-N at Biosyn and will continue...
- Biosyn Inc obtains exclusive rights to novel HIV microbicide candidate from...
- News wire article from: Asia Africa Intelligence Wire April 3, 2003 700+ words
...Based on these data, Biosyn foresees significant...the development of CV-N as a microbicide...the NIH licence, Biosyn receives exclusive...commercialisation of CV-N as a microbicide...development programme for CV-N at Biosyn and will continue...
- Biosyn, Inc. Receives up to $10 Million for the Development of a Novel HIV...
- Press release article from: PR Newswire October 2, 2003 700+ words
...We are pleased to partner with Biosyn in this effort," noted Dr. Zeda...IPM's CEO. As requested by IPM, Biosyn has committed to making the CV-N microbicide available to developing nations. Biosyn's lead product candidate, 1...
- Biosyn Inc receives up to $10 M for the development of a novel HIV fusion...
- News wire article from: Asia Africa Intelligence Wire October 2, 2003 700+ words
...advancement of cyanovirin-N (CV-N), a novel fusion...Triggers for IPM payments to Biosyn include, among other...As requested by IPM, Biosyn has committed to making the CV-N microbicide available to developing nations. Biosyn's lead product candidate...
- Biosyn, Inc. Announces $10 Million Grant from National Institutes of Health.
- Press release article from: PR Newswire November 4, 2002 700+ words
...Scientific Officer of Biosyn. "The significant support...the ability to progress CV-N forward along with...portfolio of microbicides." Biosyn is developing a number...prevention of other STDs. Biosyn's receipt of the $10...the swift progression of CV-N into clinical trials...
- Biosyn, Inc. Initiates Phase I Clinical Testing of UC-781, a Novel HIV...
- Press release article from: PR Newswire September 4, 2003 700+ words
...Corner, President & CEO of Biosyn. "This progression in our clinical program represents Biosyn's commitment to making available...women. Also in development at Biosyn are other STD prevention product...trials, and cyanovirin-N (CV-N), an HIV fusion inhibitor...
- Biosyn eyeing $10M for HIV product development.(Friday, October 3)(Brief...
- Newspaper article from: BioWorld Week October 6, 2003 700+ words
Biosyn Inc. could receive up to...subsidy to its cyanovirin-N (CV-N) program. The product...the transmission of HIV," Biosyn President and CEO Anne-Marie...initially will be triggered as Biosyn develops scaled-up production...
- Biosyn Inc announces $10 M grant from National Institutes of Health.
- News wire article from: Asia Africa Intelligence Wire November 4, 2002 700+ words
...NewsBase - Press Release) Biosyn Inc announced that the...compound, Cyanovirin-N (CV-N), as a microbicide...period of five years. CV-N is a novel protein...Studies conducted on CV-N to date have demonstrated...use as a microbicide. Biosyn Inc is developing a number...
- Biosyn, Inc. Submits Investigational New Drug Application for Novel HIV...
- Press release article from: PR Newswire June 23, 2003 700+ words
...VALLEY, Pa., June 23 /PRNewswire/ -- Biosyn, Inc. announced today that the company...development of UC-781 as an HIV microbicide. Biosyn plans to initiate clinical trials investigating...President & Chief Scientific Officer of Biosyn. "In addition, the potential exists...
- Cellegy Pharmaceuticals to Acquire Biosyn, Inc. - Part 1.
- News wire article from: The America's Intelligence Wire October 8, 2004 700+ words
...OPERATOR: Welcome to the Cellegy Acquires Biosyn Inc. conference call. At this time...Cellegy team, Anne-Marie Corner from Biosyn. But before we start, I'd like to...that we'll be developing through the Biosyn acquisition. We'll also talk about...
Source: HighBeam Research, Exclusive rights obtained to HIV microbicide candidate.(cyanovirin-N...